Published on in Vol 23, No 3 (2021): March

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/24134, first published .
A Novel Mobile App (Heali) for Disease Treatment in Participants With Irritable Bowel Syndrome: Randomized Controlled Pilot Trial

A Novel Mobile App (Heali) for Disease Treatment in Participants With Irritable Bowel Syndrome: Randomized Controlled Pilot Trial

A Novel Mobile App (Heali) for Disease Treatment in Participants With Irritable Bowel Syndrome: Randomized Controlled Pilot Trial

Journals

  1. Lam T, Cheung M, Munro Y, Lim K, Shung D, Sung J. Randomized Controlled Trials of Artificial Intelligence in Clinical Practice: Systematic Review. Journal of Medical Internet Research 2022;24(8):e37188 View
  2. Cai H, Chen H, Gao Y, Huang Q, Lv C, Cang X, Qi J, Luo K, Jin S. A preliminary study of further attempt at the development, testing and application of an independent primary screening stool card. Scientific Reports 2022;12(1) View
  3. Hershko-Moshe A, Hasin Y, Nevo-Shor A, Etzion O, Ilan Y, Maung S. Improving the Treatment Response of Patients with Irritable Bowel Syndrome: Implementing a Second-Generation Artificial Intelligence System for Overcoming Resistance. GastroHep 2022;2022:1 View
  4. Lee V, Vijayakumar S, Lau N, Blasiak A, Siah K, Ho D. Understanding the user: Patients’ perception, needs, and concerns of health apps for chronic constipation. DIGITAL HEALTH 2022;8:205520762211046 View
  5. Duan D, Liu M, Chen Y, Huang Y, Shi Y. Food Literacy and Its Associated Factors in Non-Dialysis Patients with Chronic Kidney Disease in China: A Cross-Sectional Study. Patient Preference and Adherence 2022;Volume 16:439 View
  6. Ankersen D, Weimers P, Bennedsen M, Haaber A, Fjordside E, Beber M, Lieven C, Saboori S, Vad N, Rannem T, Marker D, Paridaens K, Frahm S, Jensen L, Rosager Hansen M, Burisch J, Munkholm P. Long-Term Effects of a Web-Based Low-FODMAP Diet Versus Probiotic Treatment for Irritable Bowel Syndrome, Including Shotgun Analyses of Microbiota: Randomized, Double-Crossover Clinical Trial. Journal of Medical Internet Research 2021;23(12):e30291 View
  7. Moreno-Ligero M, Moral-Munoz J, Salazar A, Failde I. mHealth Intervention for Improving Pain, Quality of Life, and Functional Disability in Patients With Chronic Pain: Systematic Review. JMIR mHealth and uHealth 2023;11:e40844 View
  8. Staudacher H, Yao C, Chey W, Whelan K. Optimal Design of Clinical Trials of Dietary Interventions in Disorders of Gut-Brain Interaction. American Journal of Gastroenterology 2022;117(6):973 View
  9. Dimidi E, Belogianni K, Whelan K, Lomer M. Gut Symptoms during FODMAP Restriction and Symptom Response to Food Challenges during FODMAP Reintroduction: A Real-World Evaluation in 21,462 Participants Using a Mobile Application. Nutrients 2023;15(12):2683 View
  10. Colgan A, Digby K, Apekey T, Elborough‐Whitehouse I, Seamark L, Radcliffe O, Williams M, Hickson M. A dietitian‐led low‐FODMAP diet webinar: a pre–post study evaluating its impact on symptoms of irritable bowel syndrome. Journal of Human Nutrition and Dietetics 2024;37(2):396 View
  11. Yan M, Man S, Sun B, Ma L, Guo L, Huang L, Gao W. Gut liver brain axis in diseases: the implications for therapeutic interventions. Signal Transduction and Targeted Therapy 2023;8(1) View
  12. Na W, Oh D, Hwang S, Sohn C. Effect of web-based personalized nutrition management on gut microbiota in Korean patients with irritable bowel syndrome aged between 20 and 30 years. Journal of Nutrition and Health 2024;57(1):75 View

Books/Policy Documents

  1. Hennemann S, Böhme K, Witthöft M. Digitale Gesundheitsinterventionen. View